News and Press Releases

Pulmonary Hypertension

  • Tucson startup looks to human trials for drug to treat lung inflammation

    Jan 2022

  • Aqualung Therapeutics Corp., an Immunotherapeutics Biotech Company, Closes a $2.5M Convertible Note Raise With a Committed Series A Lead Investor

    January 2022

  • CEO & Founder of Aqualung Therapeutics Corp., Joe G.N. Garcia MD to Present Corporate Update at the Annual Biotech Showcase

    Dec 2021

  • Aqualung Therapeutics Selected to Present at the Phoenix 2021 Venture Madness Competition

    August 2021

  • Healing lungs, improving data, oncology research and more

    June 2020

Previous
Previous

Prostate Cancer

Next
Next

Radiation-Induced Lung Injury (RILI)